Bio-Rad Laboratories, Inc. (BIO) insider trading.
In Q3 2026, insiders at Bio-Rad Laboratories, Inc. reported 42 non-derivative transactions on 13 Forms 3, 4 and 5: 0 open-market purchases and 0 sales.
- Transactions
- 42
- Purchases (P)
- 0
- Sales (S)
- 0
- Net shares, P minus S
- 0
- Insiders
- 9
- Last filed
- 2026-09-09
Insiders
| Insider | Relationship | Transactions | Buys | Sales |
|---|---|---|---|---|
| Schwartz Norman D | Director, Officer, TenPercentOwner · Chairman & CEO | 6 | 0 | 0 |
| Allison Schwartz | Director | 6 | 0 | 0 |
| Barry James | Officer · EVP, President, LSG | 6 | 0 | 0 |
| Engelhardt Eva Anette | Officer · EVP, President, CDG | 6 | 0 | 0 |
| Lakkaraju Roop Kalyan | Officer · EVP, Chief Financial Officer | 4 | 0 | 0 |
| Evran Sedat | Officer · EVP, Global Supply Chain | 4 | 0 | 0 |
| Enloe Courtney C | Officer · EVP, General Counsel & Sec | 4 | 0 | 0 |
| Mehta Rajat | Officer · EVP, GBL Commercial Operations | 4 | 0 | 0 |
| DiVincenzo Jonathan P. | Officer · President & COO | 2 | 0 | 0 |
Transactions
| Date | Insider | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-09-06 | Schwartz Norman D | M (A) | 3,455 | $0 | 450,873 | Form 4 |
| 2026-09-06 | Schwartz Norman D | F (D) | 1,854 | $386.11 | 449,019 | Form 4 |
| 2026-09-06 | Lakkaraju Roop Kalyan | M (A) | 1,536 | $0 | 4,933 | Form 4 |
| 2026-09-06 | Lakkaraju Roop Kalyan | F (D) | 782 | $386.11 | 4,151 | Form 4 |
| 2026-09-06 | Allison Schwartz | F (D) | 34 | $386.11 | 1,734 | Form 4 |
| 2026-09-06 | Allison Schwartz | M (A) | 92 | $0 | 1,768 | Form 4 |
| 2026-09-06 | Evran Sedat | F (D) | 277 | $386.11 | 3,603 | Form 4 |
| 2026-09-06 | Evran Sedat | M (A) | 864 | $0 | 3,880 | Form 4 |
| 2026-09-06 | Enloe Courtney C | M (A) | 768 | $0 | 1,957 | Form 4 |
| 2026-09-06 | Enloe Courtney C | F (D) | 305 | $386.11 | 1,652 | Form 4 |
| 2026-09-06 | Barry James | M (A) | 1,056 | $0 | 2,495 | Form 4 |
| 2026-09-06 | Barry James | F (D) | 470 | $386.11 | 2,025 | Form 4 |
| 2026-09-06 | Engelhardt Eva Anette | M (A) | 1,152 | $0 | 2,313 | Form 4 |
| 2026-09-06 | Engelhardt Eva Anette | F (D) | 485 | $386.11 | 1,828 | Form 4 |
| 2026-09-05 | Schwartz Norman D | F (D) | 2,876 | $386.11 | 447,418 | Form 4 |
| 2026-09-05 | Schwartz Norman D | M (A) | 4,109 | $0 | 450,294 | Form 4 |
| 2026-09-05 | Lakkaraju Roop Kalyan | F (D) | 559 | $386.11 | 3,397 | Form 4 |
| 2026-09-05 | Lakkaraju Roop Kalyan | M (A) | 1,370 | $0 | 3,956 | Form 4 |
| 2026-09-05 | DiVincenzo Jonathan P. | F (D) | 668 | $386.11 | 1,963 | Form 4 |
| 2026-09-05 | DiVincenzo Jonathan P. | M (A) | 1,712 | $0 | 2,631 | Form 4 |
| 2026-09-05 | Allison Schwartz | M (A) | 228 | $0 | 1,758 | Form 4 |
| 2026-09-05 | Allison Schwartz | F (D) | 82 | $386.11 | 1,676 | Form 4 |
| 2026-09-05 | Evran Sedat | F (D) | 329 | $386.11 | 3,016 | Form 4 |
| 2026-09-05 | Evran Sedat | M (A) | 1,027 | $0 | 3,345 | Form 4 |
| 2026-09-05 | Enloe Courtney C | M (A) | 685 | $0 | 1,435 | Form 4 |
| 2026-09-05 | Enloe Courtney C | F (D) | 246 | $386.11 | 1,189 | Form 4 |
| 2026-09-05 | Barry James | F (D) | 369 | $386.11 | 1,439 | Form 4 |
| 2026-09-05 | Barry James | M (A) | 1,027 | $0 | 1,808 | Form 4 |
| 2026-09-05 | Engelhardt Eva Anette | M (A) | 1,027 | $0 | 1,530 | Form 4 |
| 2026-09-05 | Engelhardt Eva Anette | F (D) | 369 | $386.11 | 1,161 | Form 4 |
| 2026-09-05 | Mehta Rajat | M (A) | 456 | $0 | 599 | Form 4 |
| 2026-09-05 | Mehta Rajat | F (D) | 233 | $386.11 | 366 | Form 4 |
| 2026-09-05 | Mehta Rajat | M (A) | 1,370 | $0 | 1,736 | Form 4 |
| 2026-09-05 | Mehta Rajat | F (D) | 504 | $386.11 | 1,232 | Form 4 |
| 2026-09-01 | Schwartz Norman D | M (A) | 5,087 | $0 | 448,521 | Form 4 |
| 2026-09-01 | Schwartz Norman D | F (D) | 2,336 | $380.96 | 446,185 | Form 4 |
| 2026-09-01 | Allison Schwartz | F (D) | 43 | $380.96 | 1,530 | Form 4 |
| 2026-09-01 | Allison Schwartz | M (A) | 117 | $0 | 1,573 | Form 4 |
| 2026-09-01 | Barry James | M (A) | 425 | $0 | 935 | Form 4 |
| 2026-09-01 | Barry James | F (D) | 154 | $380.96 | 781 | Form 4 |
| 2026-07-25 | Engelhardt Eva Anette | F (D) | 89 | $314.46 | 503 | Form 4 |
| 2026-07-25 | Engelhardt Eva Anette | M (A) | 246 | $0 | 592 | Form 4 |
Transaction codes in this quarter
Get BIO insider transactions through the API
curl "https://sec-api.dev/api/v1/insider-transactions?period=2026q3&cik=12208&limit=100" \
-H "Authorization: Bearer $SEC_API_KEY"Insider trading API guide · BIO company page · Bio-Rad Laboratories, Inc. on SEC.gov
Questions
Are insiders buying or selling Bio-Rad Laboratories, Inc. (BIO)?
In Q3 2026, insiders at Bio-Rad Laboratories, Inc. reported 42 non-derivative transactions on 13 Forms 3, 4 and 5: 0 open-market purchases and 0 sales. Grants, tax withholding and option exercises are counted as transactions but are not purchases or sales.
Where do these Bio-Rad Laboratories, Inc. insider trades come from?
From the SEC Insider Transactions Data Sets for Q3 2026, which republish the Forms 3, 4 and 5 filed on EDGAR. Each row links to its filing on SEC.gov.
Plain-text version for agents and LLMs: /insider-trading/bio.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.